As of 2025-11-02, the Relative Valuation of MEI Pharma Inc (MEIP) is 8.05 USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.07 USD, the upside of MEI Pharma Inc based on Relative Valuation is 162.2%.
The range of the Relative Valuation is 7.63 - 10.20 USD.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | 16.8x - 22.4x | 17.7x |
| Fair Price | 7.63 - 10.20 | 8.05 |
| Upside | 148.5% - 232.1% | 162.2% |
| Date | P/E |